These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 34492695)

  • 1. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Kulkarni O; Narreddy S; Zaveri L; Kalal IG; Tallapaka KB; Sowpati DT
    Clin Infect Dis; 2021 Sep; 73(5):e1239-e1241. PubMed ID: 34492695
    [No Abstract]   [Full Text] [Related]  

  • 2. Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
    Nonaka CKV; Franco MM; Gräf T; de Lorenzo Barcia CA; de Ávila Mendonça RN; de Sousa KAF; Neiva LMC; Fosenca V; Mendes AVA; de Aguiar RS; Giovanetti M; de Freitas Souza BS
    Emerg Infect Dis; 2021 May; 27(5):1522-1524. PubMed ID: 33605869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 reinfection with a virus harboring mutation in the Spike and the Nucleocapsid proteins in Panama.
    Díaz Y; Ortiz A; Weeden A; Castillo D; González C; Moreno B; Martínez-Montero M; Castillo M; Vasquez G; Sáenz L; Franco D; Pitti Y; Chavarria O; Gondola J; Moreno AM; Ábrego L; Beltrán D; Guerra I; Chang J; Chaverra Z; Guerrero I; Valoy A; Gaitán M; Araúz D; Morán E; Chen-Germán M; Valdespino E; Rodríguez R; Corrales R; Chen-Camaño R; Pascale JM; Martínez AA; López-Vergès S;
    Int J Infect Dis; 2021 Jul; 108():588-591. PubMed ID: 34107326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants.
    Kubale J; Gleason C; Carreño JM; Srivastava K; Singh G; ; Gordon A; Krammer F; Simon V
    mBio; 2022 Oct; 13(5):e0178422. PubMed ID: 35997286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.
    Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q
    J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19.
    Focosi D; Novazzi F; Genoni A; Dentali F; Gasperina DD; Baj A; Maggi F
    Emerg Infect Dis; 2021 Oct; 27(10):2728-2731. PubMed ID: 34314668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
    Novazzi F; Baj A; Genoni A; Spezia PG; Colombo A; Cassani G; Zago C; Pasciuta R; Della Gasperina D; Ageno W; Severgnini P; Dentali F; Focosi D; Maggi F
    J Med Virol; 2021 Sep; 93(9):5648-5649. PubMed ID: 33969504
    [No Abstract]   [Full Text] [Related]  

  • 8. SARS-CoV-2 reinfection in a healthcare professional in inner Sao Paulo during the first wave of COVID-19 in Brazil.
    Camargo CH; Gonçalves CR; Pagnoca EVRG; Campos KR; Montanha JOM; Flores MNP; Soares MMCN; Binhardi FMT; Ferreira PM; Yu ALF; Carvalhanas TRMP; Abbud A; Bugno A; Sacchi CT
    Diagn Microbiol Infect Dis; 2021 Dec; 101(4):115516. PubMed ID: 34425504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study.
    Townsend JP; Hassler HB; Wang Z; Miura S; Singh J; Kumar S; Ruddle NH; Galvani AP; Dornburg A
    Lancet Microbe; 2021 Dec; 2(12):e666-e675. PubMed ID: 34632431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K.
    Di Giacomo S; Mercatelli D; Rakhimov A; Giorgi FM
    J Med Virol; 2021 Sep; 93(9):5638-5643. PubMed ID: 33951211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning from SARS and MERS: COVID-19 reinfection where do we stand?
    Al-Tawfiq JA; Rabaan AA; Al-Omari A; Al Mutair A; Al-Qahtani M; Tirupathi R
    Travel Med Infect Dis; 2021; 41():102024. PubMed ID: 33741499
    [No Abstract]   [Full Text] [Related]  

  • 12. New SARS-CoV-2 Omicron Variant with Spike Protein Mutation Y451H, Kilifi, Kenya, March-May 2023.
    Mwanga MJ; Lambisia AW; Morobe JM; Murunga N; Moraa E; Ndwiga L; Cheruiyot R; Musyoki J; Mutunga M; Guzman-Rincon LM; Sande C; Mwangangi J; Bejon P; Ochola-Oyier LI; Nokes DJ; Agoti CN; Nyiro J; Githinji G
    Emerg Infect Dis; 2023 Nov; 29(11):2376-2379. PubMed ID: 37708843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment of Severe Acute Respiratory Syndrome Coronavirus 2 Variants in the Ferret Model.
    Pulit-Penaloza JA; Belser JA; Sun X; Pappas C; Brock N; Kieran TJ; Ritter JM; Seixas JN; Jones J; Basu Thakur P; Pusch E; Wang L; Tumpey TM; Wentworth DE; Zhou B; Maines TR
    mBio; 2022 Oct; 13(5):e0242122. PubMed ID: 36135377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Neutralization Resistance Mutations in Patient with HIV/AIDS, California, USA.
    Hoffman SA; Costales C; Sahoo MK; Palanisamy S; Yamamoto F; Huang C; Verghese M; Solis DA; Sibai M; Subramanian A; Tompkins LS; Grant P; Shafer RW; Pinsky BA
    Emerg Infect Dis; 2021; 27(10):2720-2723. PubMed ID: 34296992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
    Hirotsu Y; Omata M
    PLoS Pathog; 2021 Jun; 17(6):e1009619. PubMed ID: 34097716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play.
    Souza PFN; Mesquita FP; Amaral JL; Landim PGC; Lima KRP; Costa MB; Farias IR; Lima LB; Montenegro RC
    Int J Biol Macromol; 2021 May; 179():1-19. PubMed ID: 33667553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
    Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent progress on the mutations of SARS-CoV-2 spike protein and suggestions for prevention and controlling of the pandemic.
    Li X; Zhang L; Chen S; Ji W; Li C; Ren L
    Infect Genet Evol; 2021 Sep; 93():104971. PubMed ID: 34146731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    Podder S; Ghosh A; Ghosh T
    J Med Virol; 2021 May; 93(5):2790-2798. PubMed ID: 33090493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild SARS-CoV-2 Illness Is Not Associated with Reinfections and Provides Persistent Spike, Nucleocapsid, and Virus-Neutralizing Antibodies.
    Schuler CF; Gherasim C; O'Shea K; Manthei DM; Chen J; Zettel C; Troost JP; Kennedy AA; Tai AW; Giacherio DA; Valdez R; Baldwin JL; Baker JR
    Microbiol Spectr; 2021 Oct; 9(2):e0008721. PubMed ID: 34468184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.